98 related articles for article (PubMed ID: 27508226)
21. Autophosphorylation of CaMKK2 generates autonomous activity that is disrupted by a T85S mutation linked to anxiety and bipolar disorder.
Scott JW; Park E; Rodriguiz RM; Oakhill JS; Issa SM; O'Brien MT; Dite TA; Langendorf CG; Wetsel WC; Means AR; Kemp BE
Sci Rep; 2015 Sep; 5():14436. PubMed ID: 26395653
[TBL] [Abstract][Full Text] [Related]
22. Protein ligand interaction analysis against new CaMKK2 inhibitors by use of X-ray crystallography and the fragment molecular orbital (FMO) method.
Takaya D; Niwa H; Mikuni J; Nakamura K; Handa N; Tanaka A; Yokoyama S; Honma T
J Mol Graph Model; 2020 Sep; 99():107599. PubMed ID: 32348940
[TBL] [Abstract][Full Text] [Related]
23. Activation of a Ca(2+)-dependent protein kinase involves intramolecular binding of a calmodulin-like regulatory domain.
Huang JF; Teyton L; Harper JF
Biochemistry; 1996 Oct; 35(40):13222-30. PubMed ID: 8855961
[TBL] [Abstract][Full Text] [Related]
24. Down-regulation of calcium/calmodulin-dependent protein kinase kinase 2 by androgen deprivation induces castration-resistant prostate cancer.
Shima T; Mizokami A; Miyagi T; Kawai K; Izumi K; Kumaki M; Ofude M; Zhang J; Keller ET; Namiki M
Prostate; 2012 Dec; 72(16):1789-801. PubMed ID: 22549914
[TBL] [Abstract][Full Text] [Related]
25. Ca2+/calmodulin-dependent protein kinase II from hen brain. Purification and characterization.
Gupta RP; Lapadula DM; Abou-Donia MB
Biochem Pharmacol; 1992 May; 43(9):1975-88. PubMed ID: 1317705
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of CaMKK2 reverses age-associated decline in bone mass.
Pritchard ZJ; Cary RL; Yang C; Novack DV; Voor MJ; Sankar U
Bone; 2015 Jun; 75():120-7. PubMed ID: 25724145
[TBL] [Abstract][Full Text] [Related]
27. Tryptophan fluorescence quenching by methionine and selenomethionine residues of calmodulin: orientation of peptide and protein binding.
Yuan T; Weljie AM; Vogel HJ
Biochemistry; 1998 Mar; 37(9):3187-95. PubMed ID: 9485473
[TBL] [Abstract][Full Text] [Related]
28. 14-3-3 protein inhibits CaMKK1 by blocking the kinase active site with its last two C-terminal helices.
Petrvalska O; Honzejkova K; Koupilova N; Herman P; Obsilova V; Obsil T
Protein Sci; 2023 Nov; 32(11):e4805. PubMed ID: 37817008
[TBL] [Abstract][Full Text] [Related]
29. Comparison of Ca2+/calmodulin-dependent protein kinase IV from rat brain, expressed in insect cells, and expressed in Escherichia coli.
Kitani T; Okuno S; Fujisawa H
J Biochem; 1995 Aug; 118(2):364-70. PubMed ID: 8543571
[TBL] [Abstract][Full Text] [Related]
30. Optimization of expression and purification of HSPA6 protein from Camelus dromedarius in E. coli.
Malik A; Alsenaidy AM; Elrobh M; Khan W; Alanazi MS; Bazzi MD
Saudi J Biol Sci; 2016 May; 23(3):410-9. PubMed ID: 27081368
[TBL] [Abstract][Full Text] [Related]
31. Requirement of brain extract for the activity of brain calmodulin-dependent protein kinase IV expressed in Escherichia coli.
Okuno S; Fujisawa H
J Biochem; 1993 Aug; 114(2):167-70. PubMed ID: 8262894
[TBL] [Abstract][Full Text] [Related]
32. GLUT12 promotes prostate cancer cell growth and is regulated by androgens and CaMKK2 signaling.
White MA; Tsouko E; Lin C; Rajapakshe K; Spencer JM; Wilkenfeld SR; Vakili SS; Pulliam TL; Awad D; Nikolos F; Katreddy RR; Kaipparettu BA; Sreekumar A; Zhang X; Cheung E; Coarfa C; Frigo DE
Endocr Relat Cancer; 2018 Apr; 25(4):453-469. PubMed ID: 29431615
[TBL] [Abstract][Full Text] [Related]
33. Isolation and characterization of a novel calcium/calmodulin-dependent protein kinase, AtCK, from arabidopsis.
Jeong JC; Shin D; Lee J; Kang CH; Baek D; Cho MJ; Kim MC; Yun DJ
Mol Cells; 2007 Oct; 24(2):276-82. PubMed ID: 17978582
[TBL] [Abstract][Full Text] [Related]
34. Ca
Mukherjee D; Previs RA; Haines CN; Abo MA; Juras PK; Strickland KC; Chakraborty B; Artham S; Whitaker R; Hebert KL; Fontenot J; Patierno SR; Freedman JA; Lau FH; Burow M; Chang CY; McDonnell DP
bioRxiv; 2023 Apr; ():. PubMed ID: 37131673
[TBL] [Abstract][Full Text] [Related]
35. Production of reagents and optimization of methods for studying calmodulin-binding proteins.
Ulbricht B; Soldati T
Protein Expr Purif; 1999 Feb; 15(1):24-33. PubMed ID: 10024466
[TBL] [Abstract][Full Text] [Related]
36. Regulation and role of CAMKK2 in prostate cancer.
Pulliam TL; Goli P; Awad D; Lin C; Wilkenfeld SR; Frigo DE
Nat Rev Urol; 2022 Jun; 19(6):367-380. PubMed ID: 35474107
[TBL] [Abstract][Full Text] [Related]
37. Expression and Purification of Calmodulin for NMR and Other Biophysical Applications.
Grant BMM; Marshall CB; Ikura M
Methods Mol Biol; 2019; 1929():207-221. PubMed ID: 30710275
[TBL] [Abstract][Full Text] [Related]
38. Purification of recombinant proteins based on the interaction between a phenothiazine-derivatized column and a calmodulin fusion tail.
Schauer-Vukasinovic V; Daunert S
Biotechnol Prog; 1999; 15(3):513-6. PubMed ID: 10356271
[TBL] [Abstract][Full Text] [Related]
39. Purification method for recombinant proteins based on a fusion between the target protein and the C-terminus of calmodulin.
Schauer-Vukasinovic V; Deo SK; Daunert S
Anal Bioanal Chem; 2002 Jul; 373(6):501-7. PubMed ID: 12172685
[TBL] [Abstract][Full Text] [Related]
40. Calcium/calmodulin-dependent protein kinase kinase 2 (CAMKK2) inhibitors: a novel approach in small molecule discovery.
Devasahayam Arokia Balaya R; Chandrasekaran J; Kanekar S; Kumar Modi P; Dagamajalu S; Gopinathan K; Raju R; Prasad TSK
J Biomol Struct Dyn; 2023; 41(24):15196-15206. PubMed ID: 37029757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
